Jennifer L. McKimm-Breschkin
CSIRO Molecular and Health Technologies
Parkville
Victoria
Australia
Name/email consistency: high
- Reduced sensitivity of influenza A (H5N1) to oseltamivir. McKimm-Breschkin, J.L., Selleck, P.W., Usman, T.B., Johnson, M.A. Emerging Infect. Dis. (2007)
- Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. McKimm-Breschkin, J.L. Treat. Respir. Med (2005)
- A simplified plaque assay for respiratory syncytial virus--direct visualization of plaques without immunostaining. McKimm-Breschkin, J.L. J. Virol. Methods (2004)
- Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. McKimm-Breschkin, J., Trivedi, T., Hampson, A., Hay, A., Klimov, A., Tashiro, M., Hayden, F., Zambon, M. Antimicrob. Agents Chemother. (2003)
- Tethered neuraminidase inhibitors that bind an influenza virus: a first step towards a diagnostic method for influenza. McKimm-Breschkin, J.L., Colman, P.M., Jin, B., Krippner, G.Y., McDonald, M., Reece, P.A., Tucker, S.P., Waddington, L., Watson, K.G., Wu, W.Y. Angew. Chem. Int. Ed. Engl. (2003)
- Neuraminidase inhibitors for the treatment and prevention of influenza. McKimm-Breschkin, J.L. Expert. Opin. Pharmacother (2002)